503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
11.78%
Revenue growth 50-75% of ZETA's 16.65%. Martin Whitman would scrutinize if slower growth is temporary.
No Data
No Data available this quarter, please select a different quarter.
11.78%
Gross profit growth 1.25-1.5x ZETA's 8.15%. Bruce Berkowitz would examine sustainability.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-273.15%
EBITDA decline while ZETA shows 406.86% growth. Joel Greenblatt would examine position.
-254.90%
EBITDA margin decline while ZETA shows 363.07% growth. Joel Greenblatt would examine position.
-273.15%
Operating income decline while ZETA shows 68.32% growth. Joel Greenblatt would examine position.
-254.90%
Operating margin decline while ZETA shows 72.84% growth. Joel Greenblatt would examine position.
273.15%
Other expenses growth while ZETA reduces costs. John Neff would investigate differences.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
EPS decline while ZETA shows 41.00% growth. Joel Greenblatt would examine position.
-50.00%
Diluted EPS decline while ZETA shows 41.00% growth. Joel Greenblatt would examine position.
0.68%
Share count reduction exceeding 1.5x ZETA's 2.21%. David Dodd would verify capital allocation.
0.68%
Diluted share reduction exceeding 1.5x ZETA's 2.21%. David Dodd would verify capital allocation.